{
  "id": 14271002,
  "title": "Drug tapering noninferior to treatment continuation for rheumatoid arthritis with low disease activity",
  "url": "https://urgent.news/2026/10/13/drug-tapering-noninferior-to-treatment-continuation-for-rheumatoid",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-13T19:00:24.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-drug-tapering-noninferior-treatment-rheumatoid.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "For patients with rheumatoid arthritis (RA) with sustained low disease activity (LDA), structured tapering of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) is noninferior to treatment continuation for maintaining disease control over 24 weeks, according to a study published online Oct. 6 in Arthritis & Rheumatology.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}